- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-21 in breast cancer: diagnostic and prognostic potential
Authors
Keywords
MicroRNA-21, Breast cancer, Biomarker, Diagnosis, Prognosis
Journal
Clinical & Translational Oncology
Volume 16, Issue 3, Pages 225-233
Publisher
Springer Nature
Online
2013-11-18
DOI
10.1007/s12094-013-1132-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer
- (2013) Alpaslan Özgün et al. ONKOLOGIE
- Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer
- (2013) Rom S. Leidner et al. PLoS One
- Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue
- (2013) Liang Chen et al. PLoS One
- Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
- (2013) Enders K. O. Ng et al. PLoS One
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
- (2013) Heather H. Cheng et al. PLoS One
- Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue
- (2012) Fermín MAR-AGUILAR et al. Asia-Pacific Journal of Clinical Oncology
- Expression Analysis of MiR-21, MiR-205, and MiR-342 in Breast Cancer in Iran
- (2012) Shahram Savad et al. Asian Pacific Journal of Cancer Prevention
- Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
- (2012) D. Madhavan et al. CLINICAL CANCER RESEARCH
- A Bead-Based Multiplexed Immunoassay to Evaluate Breast Cancer Biomarkers for Early Detection in Pre-Diagnostic Serum
- (2012) Annemieke Opstal-van Winden et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast
- (2012) Jung Ah Lee et al. Journal of Breast Cancer
- The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors
- (2012) Bing Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
- (2012) Haiyan Si et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps
- (2011) Chung Wah Wu et al. GUT
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of differentially expressed microRNAs in human male breast cancer
- (2010) Ulrich Lehmann et al. BMC CANCER
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
- (2010) Nobuyoshi Kosaka et al. CANCER SCIENCE
- Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
- (2010) S. Asaga et al. CLINICAL CHEMISTRY
- Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
- (2010) Fengjun Wang et al. GYNECOLOGIC ONCOLOGY
- MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
- (2010) Bao Song et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
- (2010) H. M. Heneghan et al. ONCOLOGIST
- A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
- (2010) Hua Zhao et al. PLoS One
- Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner
- (2009) Luize G. Lima et al. CANCER LETTERS
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
- (2009) Nalinie S. Wickramasinghe et al. NUCLEIC ACIDS RESEARCH
- Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach
- (2009) Yi Yang et al. PROTEOMICS
- Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
- (2009) A. Zernecke et al. Science Signaling
- High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
- (2008) Biyun Qian et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
- (2008) Shuomin Zhu et al. CELL RESEARCH
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
- (2008) C. Camps et al. CLINICAL CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer
- (2008) Masahiro Uehara et al. International Journal of Clinical Oncology
- MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
- (2008) Z Lu et al. ONCOGENE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started